Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,633 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and Efficacy of Mesenchymal Stem Cells for Radiation-Induced Xerostomia: A Randomized, Placebo-Controlled Phase 1/2 Trial (MESRIX).
Grønhøj C, Jensen DH, Vester-Glowinski P, Jensen SB, Bardow A, Oliveri RS, Fog LM, Specht L, Thomsen C, Darkner S, Jensen M, Müller V, Kiss K, Agander T, Andersen E, Fischer-Nielsen A, von Buchwald C. Grønhøj C, et al. Among authors: muller v. Int J Radiat Oncol Biol Phys. 2018 Jul 1;101(3):581-592. doi: 10.1016/j.ijrobp.2018.02.034. Epub 2018 Mar 6. Int J Radiat Oncol Biol Phys. 2018. PMID: 29678523 Clinical Trial.
Change of saliva composition with radiotherapy.
Müller VJ, Belibasakis GN, Bosshard PP, Wiedemeier DB, Bichsel D, Rücker M, Stadlinger B. Müller VJ, et al. Arch Oral Biol. 2019 Oct;106:104480. doi: 10.1016/j.archoralbio.2019.104480. Epub 2019 Jul 10. Arch Oral Biol. 2019. PMID: 31325717
Advanced aspects of acetogens.
Poehlein A, Zeldes B, Flaiz M, Böer T, Lüschen A, Höfele F, Baur KS, Molitor B, Kröly C, Wang M, Zhang Q, Fan Y, Chao W, Daniel R, Li F, Basen M, Müller V, Angenent LT, Sousa DZ, Bengelsdorf FR. Poehlein A, et al. Among authors: muller v. Bioresour Technol. 2024 Dec 1:131913. doi: 10.1016/j.biortech.2024.131913. Online ahead of print. Bioresour Technol. 2024. PMID: 39626805 Review.
Expert recommendations on treatment sequencing and challenging clinical scenarios in human epidermal growth factor receptor 2-positive (HER2-positive) metastatic breast cancer.
Bartsch R, Cameron D, Ciruelos E, Criscitiello C, Curigliano G, Duhoux FP, Foukakis T, Gligorov J, Harbeck N, LeVasseur N, Okines A, Penault-Llorca F, Müller V. Bartsch R, et al. Among authors: muller v. Cancer Treat Rev. 2024 Nov 14;132:102853. doi: 10.1016/j.ctrv.2024.102853. Online ahead of print. Cancer Treat Rev. 2024. PMID: 39580869 Free article. Review.
Emergence of Escherichia coli ST131 carrying carbapenemase genes, European Union/European Economic Area, August 2012 to May 2024.
Kohlenberg A, Svartström O, Apfalter P, Hartl R, Bogaerts P, Huang TD, Chudejova K, Malisova L, Eisfeld J, Sandfort M, Hammerum AM, Roer L, Räisänen K, Dortet L, Bonnin RA, Tóth Á, Tóth K, Clarke C, Cormican M, Griškevičius A, Khonyongwa K, Meo M, Niedre-Otomere B, Vangravs R, Hendrickx AP, Notermans DW, Samuelsen Ø, Caniça M, Manageiro V, Müller V, Mäkitalo B, Kramar U, Pirs M, Palm D, Monnet DL, Alm E, Linkevicius M. Kohlenberg A, et al. Among authors: muller v. Euro Surveill. 2024 Nov;29(47):2400727. doi: 10.2807/1560-7917.ES.2024.29.47.2400727. Euro Surveill. 2024. PMID: 39574387 Free PMC article.
Molecular adaptation to neoadjuvant immunotherapy in triple-negative breast cancer.
Denkert C, Schneeweiss A, Rey J, Karn T, Hattesohl A, Weber KE, Rachakonda S, Braun M, Huober J, Jank P, Sinn HP, Zahm DM, Felder B, Hanusch C, Teply-Szymanski J, Marmé F, Fehm T, Thomalla J, Sinn BV, Stiewe T, Marczyk M, Blohmer JU, van Mackelenbergh M, Schem C, Staib P, Link T, Müller V, Stickeler E, Stover DG, Solbach C, Metzger-Filho O, Jackisch C, Geyer CE Jr, Fasching PA, Pusztai L, Nekljudova V, Untch M, Loibl S. Denkert C, et al. Among authors: muller v. Cell Rep Med. 2024 Nov 19;5(11):101825. doi: 10.1016/j.xcrm.2024.101825. Cell Rep Med. 2024. PMID: 39566464 Free PMC article. Clinical Trial.
The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype.
Ziegler P, Hartkopf AD, Wallwiener M, Häberle L, Kolberg HC, Hadji P, Tesch H, Ettl J, Lüftner D, Müller V, Michel LL, Belleville E, Wimberger P, Hielscher C, Huebner H, Uhrig S, Wurmthaler LA, Hack CC, Mundhenke C, Kurbacher C, Fasching PA, Wuerstlein R, Untch M, Janni W, Taran FA, Lux MP, Wallwiener D, Brucker SY, Fehm TN, Schneeweiss A, Goossens C. Ziegler P, et al. Among authors: muller v. BMC Cancer. 2024 Oct 16;24(1):1284. doi: 10.1186/s12885-024-13038-3. BMC Cancer. 2024. PMID: 39415149 Free PMC article.
1,633 results